Log in to save to my catalogue

T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experiment...

T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experiment...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733864520

T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis

About this item

Full title

T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2010-04, Vol.16 (4), p.406-412

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Interferon-β (IFN-β) is a mainstay therapy for multiple sclerosis. However, only two thirds of patients respond to therapy, and clinical symptoms worsen in some patients. Chandar Raman and his colleagues show that IFN-β alleviates disease induced by T helper type 1 cells and exacerbates disease induced by T helper type 17 cells in mice. They also s...

Alternative Titles

Full title

T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_733864520

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733864520

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm.2110

How to access this item